| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000020296 |
| Receipt No. | R000023279 |
| Scientific Title | Exploratory analysis of exosomes derived from ascites and serum of patients with peritonitis carcinomatosa |
| Date of disclosure of the study information | 2015/12/24 |
| Last modified on | 2022/01/05 (Ver. 5) |
| Basic information | ||
| Public title | Exploratory analysis of exosomes derived from ascites and serum of patients with peritonitis carcinomatosa | |
| Acronym | Exploratory analysis of exosomes derived from ascites and serum of patients with peritonitis carcinomatosa | |
| Scientific Title | Exploratory analysis of exosomes derived from ascites and serum of patients with peritonitis carcinomatosa | |
| Scientific Title:Acronym | Exploratory analysis of exosomes derived from ascites and serum of patients with peritonitis carcinomatosa | |
| Region |
|
|
| Condition | |||
| Condition | Gastrointestinal cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Exploration of predictive markers for chemoresistance and prognosis |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Relationship between exosome-derived melecules and chemoresistance/prognosis |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | abdominocentesis
(a period of time:-March 31 2018, an amout:20ml, times:1-several time) |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients who underwent abdominocentesis and/or cell-free and concentrated ascites reinfusion therapy (CART)
2. Written informed consent for participation in this study is obtained 3. > 20 years-old |
|||
| Key exclusion criteria | 1. Patients with the bleeding tendency
2. Patients with the infection or side vice-blood circulation road in the puncture part 3. Patients with the adhesion in a wide range of abdominal cavity or the high intestinal tract expansion 4. Patients who cannot keep rest 5. Patients who has extremely decreased whole body state 6. Patients who cannot carry out this examination safely |
|||
| Target sample size | 48 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Department of Medicine, Kurume University School of Medicine | ||||||
| Division name | Division of Gastroenterology | ||||||
| Zip code | 830-0011 | ||||||
| Address | 67, Asahi-machi, Kurume City, Fukuoka Prefecture | ||||||
| TEL | 0942-31-7561 | ||||||
| tori@med.kurume-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Department of Medicine, Kurume University School of Medicine | ||||||
| Division name | Division of Gastroenterology | ||||||
| Zip code | 830-0011 | ||||||
| Address | 67, Asahi-machi, Kurume City, Fukuoka Prefecture | ||||||
| TEL | 0942-31-7561 | ||||||
| Homepage URL | |||||||
| sakaue_takahiko@med.kurume-u.ac.jp | |||||||
| Sponsor | |
| Institute | Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Clinical Research Center, Kurume University |
| Address | 67, Asahi-machi, Kurume City, Fukuoka Prefecture |
| Tel | 0942-65-3749 |
| i_rinri@kurume-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023279 |